- ICH GCP
- US Clinical Trials Registry
- Search trials
Søk i kliniske studier for: Immune response and safety profile to a Tdap booster
Totalt 497495 resultater
-
National Institute of Allergy and Infectious Diseases...National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National... og andre samarbeidspartnereFullført
-
National Institute of Allergy and Infectious Diseases...TilbaketrukketHIV-infeksjoner | Pneumokokkinfeksjoner
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...FullførtHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...FullførtHIV-infeksjonerForente stater, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...Novartis Vaccines and Diagnostics, IncFullført
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials Network; IPPOX Foundation; Center for HIV/AIDS Vaccine...Tilbaketrukket
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater, Sveits
-
National Institute of Allergy and Infectious Diseases...GeoVax, Inc.Fullført
-
National Institute of Allergy and Infectious Diseases...IPPOX Foundation; EuroVacc Foundation; Global Solutions for Infectious DiseasesTilbaketrukket
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials Network; IPPOX Foundation; EuroVacc Foundation; Global Solutions...Tilbaketrukket
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkFullført
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkFullført
-
National Institute of Allergy and Infectious Diseases...Bavarian Nordic; HIV Vaccine Trials Network; Pharmexa-EpimmuneFullført
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkFullførtHIV-infeksjonerForente stater, Sør-Afrika
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerBotswana, Forente stater
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjoner | HIV-seronegativitetForente stater
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater, Brasil
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkFullførtSikkerhet og immunrespons på forebyggende HIV-immunisering med adenovirus serotype 5 eller 35 vektorHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater
-
National Institute of Allergy and Infectious Diseases...Fullført
-
GlaxoSmithKlineFullførtRespiratoriske lidelserTyskland, Canada, Storbritannia
-
National Institute of Allergy and Infectious Diseases...FullførtHumant immunsviktvirus (HIV) | Forebygging av humant immunsviktvirusForente stater
-
BayerCureVacTilbaketrukketCoronavirus Disease 2019 (COVID-19) | SARS-CoV-2-infeksjon
-
AbbVieFullførtLeddgiktForente stater, Bulgaria, Chile, Tsjekkia, Ungarn, Israel, Latvia, Mexico, Polen, Puerto Rico, Den russiske føderasjonen, Slovakia, Sør-Afrika, Spania, Tyrkia, Ukraina
-
National Institute of Allergy and Infectious Diseases...FullførtRespiratoriske syncytiale virusinfeksjonerForente stater
-
GlaxoSmithKlineAvsluttet
-
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.FullførtRespiratoriske syncytiale virusinfeksjonerAustralia
-
Novartis VaccinesFullførtInfluensa | Sesongbetinget influensa | Menneskelig influensa | Influensa på grunn av uspesifisert influensavirusBelgia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyAvsluttetSystemisk lupus erythematosusFilippinene, Forente stater, Korea, Republikken, Malaysia, Taiwan, Tyskland, Italia, Polen, Mexico, Bulgaria, Peru, Argentina, Chile, Colombia, Japan, Mauritius, Romania, Den russiske føderasjonen, Sør-Afrika
-
U.S. Army Medical Research and Development CommandUnited States Agency for International Development (USAID); Walter Reed...Fullført
-
Chulalongkorn UniversityFullførtSikkerhetsproblemerThailand
-
National Cancer Institute (NCI)FullførtBrystkreft | Eggstokkreft | Lungekreft | Prostatakreft | Svulster (andre)Forente stater
-
GlaxoSmithKlineFullførtRespiratoriske lidelserFrankrike, Tyskland, Spania, Forente stater, Belgia, Italia, Canada, Storbritannia
-
Radboud University Medical CenterGlaxoSmithKlineFullførtHIV-infeksjon | SoppinfeksjonNederland
-
National Institute of Allergy and Infectious Diseases...Fullført